FlandersBio on Twitter

Dr. Paul Janssen award voor het eerst naar een Belg: http://tiny.cc/kz3u2

posted 12 hours ago

Follow us on Twitter

News

Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

ThromboGenics Raises € 0.6 Million from the Exercise of Warrants

26/03/2010

ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, today announces that it has raised € 0.6 million as the result of the exercise of warrants by a number of the Company’s employees.

The 96.667 shares created as a result of this warrant exercise are now listed on Euronext Brussels. Following this transaction, ThromboGenics now has 29.156.234 shares outstanding.

Source: ThromboGenics

Tags: stock market

Filter by Tags

financing research merger or acquisition stock market new products clinical trials awards management alliances legal regulatory collaborations infrastructure medical biotech medtech bioenergy cinbios gmo new company

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Archive

Back to top

Print